NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
March 30, 2026 — The American Heart Association and Additional Ventures commit $20M to improve care for Fontan circulation patients, aiming to predict and prevent complications in single ventricle heart disease through collaborative research.
March 30, 2026 — Dr. Patrick Ojo, author of "FREEDOM FOR PHARMACY," signs with Creative Management Partners (CMP). CMP will manage his book, sequel, docuseries, & commercial rights.
March 30, 2026 — New AI research shows thymus health boosts immunotherapy success, cutting cancer death risks by half. TinyGems reports on implications for companies like Calidi Biotherapeutics.
March 30, 2026 — BioStem Technologies files audited financial statements for 2024-2025, advancing toward Nasdaq uplisting. Learn about their regenerative medicine products and corporate milestones.
March 30, 2026 — AI Maverick Intel announces intent to acquire HEAL Access Canada, gaining a platform in AI-enabled healthcare. Deal includes 20M shares and a $5M note, aiming for completion by 2026.
March 30, 2026 — SS Innovations gains regulatory approval for its SSi Mantra surgical robotic system in Colombia, Oman, Sri Lanka, and Kenya, expanding affordable robotic surgery access globally.
March 30, 2026 — LIXTE Biotechnology expands LB-100 clinical trial for ovarian clear cell cancer, doubling patient enrollment to test novel combination therapy approach against treatment-resistant tumors.
March 30, 2026 — NYIT expert Alexander Lopez reveals how exercise programs aid children with autism, improving motor skills, brain function, and independence. Learn practical tips for parents during Autism Acceptance Month.
March 30, 2026 — American Heart Association highlights walking on National Walking Day to fight sedentary risks. Learn how 150 minutes weekly improves heart health and reduces disease.
March 30, 2026 — FastBlast launches its Daily Essentials supplement on Amazon, offering organic, vegan nutrition with 30 superfoods. Learn how this expansion makes whole-food wellness more accessible across the U.S.
March 28, 2026 — 10X Health appoints Jeff Zwiefel as President & COO and expands executive team to accelerate global growth in precision health, human performance, and longevity solutions.
March 28, 2026 — Ezalife reports strong early sales and $1.6M institutional investment for its Button Huggie® feeding tube device as its StartEngine equity crowdfunding campaign nears close on April 6.
March 27, 2026 — Forian Inc. reports 50% revenue growth for 2025, achieves Adjusted EBITDA targets, and receives acquisition proposal from CEO-led consortium. Life sciences data analytics leader expands market presence.
March 27, 2026 — Lixte Biotech advances precision oncology with LB-100 therapy and Liora Technologies partnership. Learn how this innovation enhances cancer treatment efficacy while reducing side effects through data integration.
March 27, 2026 — Aptevo's mipletamig shows 86% clinical benefit rate in AML trial with no cytokine release syndrome. New data suggests potential to enhance frontline treatment for older patients.
March 27, 2026 — Ethema Health names James Poage as CFO to enhance SEC filings and drive growth in substance use disorder treatment. Learn how this impacts financial strategy.
March 27, 2026 — Sigyn Therapeutics unveils CardioDialysis, a single-device technology to reduce heart attacks and strokes by clearing inflammatory molecules, deployable on existing dialysis machines for wider access.
March 27, 2026 — Researchers discover hidden brake in immune cells that limits cancer-fighting ability, potentially reshaping immunotherapy approaches for patients unresponsive to current treatments.
March 27, 2026 — Lantern Pharma receives FDA clearance for Phase 1 pediatric trial of STAR-001 targeting brain cancers. AI-driven drug development shows promise for aggressive pediatric malignancies with unmet needs.
March 27, 2026 — Catalyst Crew Technologies announces CardioAI, an AI-powered platform for cardiovascular risk assessment and predictive modeling targeting Latin American healthcare markets.